SWTX |
SpringWorks Therapeutics, Inc. |
10%+ Owner |
$233 M |
|
|
Sep 12, 2022 |
EWTX |
Edgewise Therapeutics, Inc. |
Director, 10%+ Owner |
$228 M |
+$5 M |
+2.24% |
Jan 23, 2024 |
ELVN |
Enliven Therapeutics, Inc. |
Director, 10%+ Owner |
$170 M |
-$22.9 M |
-11.9% |
May 16, 2024 |
THRD |
Third Harmonic Bio, Inc. |
Director, 10%+ Owner |
$59.5 M |
|
|
Sep 19, 2022 |
NPCE |
NeuroPace Inc |
10%+ Owner |
$47.8 M |
-$8.69 M |
-15.4% |
May 1, 2024 |
PRLD |
Prelude Therapeutics Inc |
Director, 10%+ Owner |
$38.2 M |
|
|
May 22, 2023 |
SCPH |
scPharmaceuticals Inc. |
10%+ Owner |
$34 M |
|
|
Nov 25, 2022 |
SPRY |
ARS Pharmaceuticals, Inc. |
Director |
$30.3 M |
+$3.1 M |
+11.4% |
Aug 29, 2023 |
CMPX |
Compass Therapeutics, Inc. |
Director, 10%+ Owner |
$29.4 M |
|
|
Nov 8, 2022 |
ETNB |
89bio, Inc. |
10%+ Owner |
$21.1 M |
|
|
Jan 25, 2022 |
TERN |
Terns Pharmaceuticals, Inc. |
Director, 10%+ Owner |
$18.5 M |
|
|
Dec 23, 2022 |
TELA |
TELA Bio, Inc. |
10%+ Owner |
$10.9 M |
-$2.02 M |
-15.6% |
Jun 28, 2024 |
IRON |
Disc Medicine, Inc. |
Director |
$8.47 M |
-$29.6 M |
-77.7% |
Jun 17, 2024 |
VRNA |
Verona Pharma plc |
Director |
$7.46 M |
|
|
May 11, 2023 |
PASG |
Passage BIO, Inc. |
10%+ Owner |
$7.31 M |
|
|
Jun 27, 2023 |
ACET |
Adicet Bio, Inc. |
Director, 10%+ Owner |
$3.01 M |
+$7.5 M |
|
Jan 25, 2024 |
AFIB |
Acutus Medical, Inc. |
Director, 10%+ Owner |
$2.62 M |
|
|
Jul 19, 2021 |
CRVS |
Corvus Pharmaceuticals, Inc. |
Director, 10%+ Owner |
$2.5 M |
+$2.5 M |
|
May 6, 2024 |
ARQT |
Arcutis Biotherapeutics, Inc. |
10%+ Owner |
$1.47 M |
|
|
Jun 24, 2022 |
JANX |
Janux Therapeutics, Inc. |
Director |
$1.36 M |
|
|
Dec 29, 2021 |
FIXX |
Q32 Bio Inc. |
Director, 10%+ Owner |
$1.29 M |
|
|
Mar 25, 2024 |
GLTO |
Galecto, Inc. |
10%+ Owner |
$1.13 M |
-$1.83 M |
-61.7% |
Aug 15, 2023 |
ONTX |
Traws Pharma, Inc. |
Other* |
$941 K |
|
|
Apr 1, 2024 |
IKNA |
Ikena Oncology, Inc. |
Director |
$489 K |
|
|
Aug 4, 2023 |
XTNT |
Xtant Medical Holdings, Inc. |
Director, 10%+ Owner |
$263 K |
|
|
Aug 15, 2022 |
RPTX |
Repare Therapeutics Inc. |
Director |
$233 K |
|
|
Sep 3, 2021 |
ALPN |
ALPINE IMMUNE SCIENCES, INC. |
Director |
$0 |
-$28.7 M |
-100% |
May 18, 2024 |
KNTE |
Kinnate Biopharma Inc. |
Director, 10%+ Owner |
$0 |
|
|
Apr 3, 2024 |
THRX |
Theseus Pharmaceuticals, Inc. |
Director, 10%+ Owner |
$0 |
+$1.46 M |
|
Feb 14, 2024 |
AVBP |
ArriVent BioPharma, Inc. |
Director, 10%+ Owner |
|
|
|
Jan 30, 2024 |
PMVP |
PMV Pharmaceuticals, Inc. |
10%+ Owner |
|
-$196 K |
|
Nov 22, 2023 |
SRRA |
Sierra Oncology, Inc. |
Director, 10%+ Owner |
|
|
|
Jul 1, 2022 |
TCDA |
Tricida, Inc. |
Director, 10%+ Owner |
|
|
|
Nov 22, 2022 |
TSBX |
Turnstone Biologics Corp. |
Director, 10%+ Owner |
|
+$5 M |
|
Jul 20, 2023 |